Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Cash from Financing Activities (2018 - 2025)

Historic Cash from Financing Activities for Exagen (XGN) over the last 8 years, with Q3 2025 value amounting to $2.9 million.

  • Exagen's Cash from Financing Activities rose 253801.65% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.6 million, marking a year-over-year increase of 378860.57%. This contributed to the annual value of -$663000.0 for FY2024, which is 9376.41% up from last year.
  • As of Q3 2025, Exagen's Cash from Financing Activities stood at $2.9 million, which was up 253801.65% from $21.9 million recorded in Q2 2025.
  • Over the past 5 years, Exagen's Cash from Financing Activities peaked at $65.1 million during Q1 2021, and registered a low of -$10.2 million during Q2 2023.
  • Over the past 5 years, Exagen's median Cash from Financing Activities value was -$108000.0 (recorded in 2023), while the average stood at $4.1 million.
  • Per our database at Business Quant, Exagen's Cash from Financing Activities surged by 12770980.39% in 2021 and then crashed by 377954.55% in 2023.
  • Quarter analysis of 5 years shows Exagen's Cash from Financing Activities stood at -$213000.0 in 2021, then increased by 18.78% to -$173000.0 in 2022, then decreased by 27.17% to -$220000.0 in 2023, then increased by 1.82% to -$216000.0 in 2024, then surged by 1465.74% to $2.9 million in 2025.
  • Its Cash from Financing Activities stands at $2.9 million for Q3 2025, versus $21.9 million for Q2 2025 and -$64000.0 for Q1 2025.